homefeedbacksupportlog on 2-Dec-2008 
  Search
 
   
 
  Browse
ALL OF MEDICINE

Urology
Benign Bladder & Urethral Disorders
Benign Prostatic Hyperplasia & Prostatitis
Lower Urinary Tract: Dysfunction, Incontinence & Urodynamics
Male Infertility
Male Sexual Dysfunction
New Technology
Pediatric Urology
Stones & Endourology
Urological Infections
Related Sections
Genitourinary Cancers
Reproductive Endocrinology
Sexual Dysfunction
Sexually Transmitted Diseases (without HIV)

profile subject selected for My F1000 Medicine

Browse > Urology > Lower Urinary Tract: Dysfunction, Incontinence & Urodynamics
Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed
(from all journals) / Most viewed
(from specialty journals) / Hidden jewels		Page 1 of 4. Select Page: 1 2 3 4 >>
Display 10 / 20 / 50 papers per page

printer friendly 
to email [Help]

Recommended
F1000 Factor 3.0

Confirmation
 Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L
J Urol 2008 Oct 180(4):1228-34 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Viorel Bucuras with Razvan Bardan
Evaluated 17 Nov 2008

Must Read
F1000 Factor 6.0

New Finding
 Prevalence of symptomatic pelvic floor disorders in US women.
Nygaard I, Barber MD, …, Brody DJ, Pelvic Floor Disorders Network
JAMA 2008 Sep 17 300(11):1311-6 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Linda Brubaker
Evaluated 5 Nov 2008

Must Read
F1000 Factor 6.0

New Finding
 Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome.
Desireddi NV, Campbell PL, …, Koch AE, Schaeffer AJ
J Urol 2008 May 179(5):1857-61; discussion 1861-2 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michel Pontari
Evaluated 30 Oct 2008

Recommended
F1000 Factor 3.0

Confirmation
New Finding
 A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Stief CG, Porst H, …, Beneke M, Ulbrich E
Eur Urol 2008 Jun 53(6):1236-44 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Stavros Gravas
Evaluated 19 Sep 2008

Recommended
F1000 Factor 3.0

Hypothesis
 Predictors of success with postoperative voiding trials after a mid urethral sling procedure.
Wheeler TL, Richter HE, …, Redden DT, Varner RE
J Urol 2008 Feb 179(2):600-4 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Marcus  Drake with Ahmed Shaban
Evaluated 18 Sep 2008

Recommended
F1000 Factor 3.0

Confirmation
 Sites of Pain from Interstitial Cystitis/Painful Bladder Syndrome.
Warren JW, Langenberg P, …, Jacobs S, Wesselmann U
J Urol 2008 Aug 14 [abstract on PubMed] [related articles] [full text]
Selected by | Philip Hanno
Evaluated 12 Sep 2008

Recommended
F1000 Factor 3.0

Hypothesis
 Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.
Kaplan SA, Roehrborn CG, …, Nyberg LM, Medical Therapy of Prostatic Symptoms Research Group
J Urol 2008 Sep 180(3):1030-2; discussion 1032-3 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Eric Rovner with Brett Lebed
Evaluated 5 Sep 2008

Recommended
F1000 Factor 3.0

Hypothesis
New Finding
 Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder.
Liu HT, Kuo HC
J Urol 2008 Jun 179(6):2270-4 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Roger Dmochowski
Evaluated 29 Aug 2008

Must Read
F1000 Factor 6.0

Hypothesis
 Cell signaling in interstitial cystitis/painful bladder syndrome.
Keay S
Cell Signal 2008 Jun 19 [abstract on PubMed] [related articles] [full text]
Selected by | Philip Hanno
Evaluated 30 Jul 2008

Recommended
F1000 Factor 3.0

Tech Advance
 An adjustable continence therapy device for treating incontinence after prostatectomy: a minimum 2-year follow-up.
Gilling PJ, Bell DF, …, Reuther R, Fraundorfer MR
BJU Int 2008 Jun 17 [abstract on PubMed] [related articles] [full text]
Selected by | William Jaffe
Evaluated 16 Jul 2008


top of pagePage 1 of 4. Select Page: 1 2 3 4 >>
Display 10 / 20 / 50 papers per page

© 2008 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info